Skullcandy, Inc. Reports Fourth Quarter and 2015 Results
Mar 02, 2016 21:05 pm UTC| Business
PARK CITY, Utah, March 02, 2016 -- Skullcandy, Inc. (NASDAQ:SKUL), which creates world-class audio experiences through its Skullcandy® and Astro Gaming® brands, today announced financial results for the fourth quarter...
KemPharm, Inc. to Report Fourth Quarter and Year End 2015 Results
Mar 02, 2016 21:05 pm UTC| Business
CORALVILLE, Iowa, March 02, 2016 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that the Company will...
Ultragenyx to Present at the Cowen and Company 36th Annual Health Care Conference
Mar 02, 2016 21:05 pm UTC| Business
NOVATO, Calif., March 02, 2016 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that Shalini...
Sunrun to Present at the 28th Annual ROTH Conference
Mar 02, 2016 21:05 pm UTC| Business
SAN FRANCISCO, March 02, 2016 -- Sunrun (Nasdaq:RUN), the largest dedicated residential solar company in the United States, today announced that Bob Komin, chief financial officer, will present at the 28th Annual ROTH...
Revance Releases Fourth Quarter and Full Year 2015 Results
Mar 02, 2016 21:05 pm UTC| Business
- Announces 2016 Outlook --On Track to Achieve Multiple Clinical Development Milestones in 2016 - NEWARK, Calif., March 02, 2016 -- Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing...
The Habit Restaurants, Inc. Announces Fourth Quarter and Full Year 2015 Financial Results
Mar 02, 2016 21:05 pm UTC| Business
IRVINE, Calif., March 02, 2016 -- The Habit Restaurants, Inc. (NASDAQ:HABT) (“The Habit” or the “Company”), today announced financial results for its fourth quarter and full year ended December 29, 2015. Highlights...
Cesca Therapeutics Announces 1-for-20 Reverse Split of Common Stock
Mar 02, 2016 21:05 pm UTC| Business
RANCHO CORDOVA, Calif., March 02, 2016 -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced stockholder approval of a reverse split of Cesca Therapeutics Inc...